Press/Media
- 225 - 250 out of 630 results
Search results
-
Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds
27/01/22 → 29/01/22
9 items of Media coverage
Press/Media
-
Immunotherapy before surgery may benefit patients with liver cancers
28/01/22
1 item of Media coverage
Press/Media
-
Neoadjuvant cemiplimab promising for resectable liver cancer
27/01/22 → 28/01/22
2 items of Media coverage
Press/Media
-
Launching the Institute for Airway Sciences with Eric Genden, MD, MBA
25/01/22
2 items of Media coverage
Press/Media
-
Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells.
Thomas Marron & Miriam Merad
20/01/22
1 item of Media coverage
Press/Media
-
Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells; Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial, Mount Sinai r
Thomas Marron & Miriam Merad
19/01/22 → 20/01/22
2 items of Media coverage
Press/Media
-
Immunotherapy Before Surgery Confirmed to Help Against Liver Cancer
20/01/22
1 item of Media coverage
Press/Media
-
Immunotherapy before liver cancer surgery can kill tumour, and likely residual cancer cells
19/01/22
1 item of Media coverage
Press/Media
-
Mount Sinai Launches Institute for Airway Sciences
Marek Mlodzik & Charles Powell
12/01/22 → 15/01/22
4 items of Media coverage
Press/Media
-
Ten Medical and Scientific Breakthroughs of 2021 at Mount Sinai
Samir Parekh, Thomas Fuchs, Thomas Marron, Cheryl Corcoran & Robert Hirten
28/12/21 → 30/12/21
2 items of Media coverage
Press/Media
-
Dr. Galsky the Evolution of Standard Options in Urothelial Carcinoma
23/12/21
1 item of Media coverage
Press/Media
-
Rusfertide Leads to Hematocrit Control in Patients With Polycythemia Vera
17/12/21
1 item of Media coverage
Press/Media
-
Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting
12/12/21 → 13/12/21
80 items of Media coverage
Press/Media
-
Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting'
12/12/21
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Potentially Serious Side Effect Seen in Patient after Immunotherapy
Samir Parekh, Miriam Merad, Seunghee Kim-Schulze, Joshua Brody, Adeeb Rahman & Sundar Jagannath
10/12/21 → 11/12/21
8 items of Media coverage
Press/Media
-
CURE® Celebrates Eight Individuals’ Contributions at the 9th Annual MPN Heroes ProgramArticle
9/12/21
1 item of Media coverage
Press/Media
-
Dr. Galsky on Developments in SOC Metastatic Urothelial Cancer Treatment
22/11/21
1 item of Media coverage
Press/Media
-
Scientists identify new types of a blood cancer and potential targeted treatments
David Melnekoff, Joshua Richter, Samir Parekh, Violetta V. Leshchenko, Ajai Chari & Sundar Jagannath
17/11/21
1 item of Media coverage
Press/Media
-
Antengene To Release Preliminary Results Of Selinexor For The Treatment Of Peripheral T-Cell Lymphoma And NK/T-Cell Lymphoma At The 2021 ASH Annual Meeting
9/11/21
38 items of Media coverage
Press/Media
-
CURE® Honors Oncologists, Patient Advocate in Lung Cancer Heroes® Award Program for on Impact Lung Cancer CommunityArticle
Ramon Parsons,, Matthew Galsky,, Fred Hirsch, Fred Hirsch & Kenneth Rosenzweig
29/10/21
2 items of Media coverage
Press/Media
-
Clinical Trial: Pediatric GVHD Low Risk Steroid Taper Trial
23/10/21
2 items of Media coverage
Press/Media